|
US3993071A
(en)
|
1971-09-09 |
1976-11-23 |
Alza Corporation |
Bioerodible ocular device
|
|
US3949750A
(en)
|
1974-10-07 |
1976-04-13 |
Freeman Jerre M |
Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
|
|
US4915684A
(en)
|
1988-06-21 |
1990-04-10 |
Mackeen Donald L |
Method and apparatus for modulating the flow of lacrimal fluid through a punctum and associated canaliculus
|
|
US5469867A
(en)
|
1992-09-02 |
1995-11-28 |
Landec Corporation |
Cast-in place thermoplastic channel occluder
|
|
US6027470A
(en)
|
1998-06-10 |
2000-02-22 |
Eagle Vision, Inc. |
Punctum plug and method for inserting the same into the punctual opening
|
|
US5902598A
(en)
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
|
US6646001B2
(en)
|
1997-12-19 |
2003-11-11 |
Alcon Manufacturing, Ltd. |
Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
|
|
US6196993B1
(en)
|
1998-04-20 |
2001-03-06 |
Eyelab Group, Llc |
Ophthalmic insert and method for sustained release of medication to the eye
|
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
|
US6632457B1
(en)
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
|
US7347850B2
(en)
|
1998-08-14 |
2008-03-25 |
Incept Llc |
Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
|
|
US6509327B1
(en)
|
1998-09-30 |
2003-01-21 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating otic, ophthalmic and nasal infections
|
|
JP2002531217A
(ja)
|
1998-12-04 |
2002-09-24 |
チャンドラシェカー ピー． パサック， |
生体適合性架橋ポリマー
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
AU2417201A
(en)
|
1999-12-17 |
2001-06-25 |
Magnus Qvist |
New use of a bioadhesive composition comprising a polyphenolic protein
|
|
US20040175410A1
(en)
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1339438B1
(en)
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Preventing transplant rejection in the eye
|
|
US6982090B2
(en)
|
2001-05-10 |
2006-01-03 |
Gillespie Donald E |
More easily visualized punctum plug configurations
|
|
CN1301692C
(zh)
|
2002-09-18 |
2007-02-28 |
阿勒根公司 |
眼植入物导入的器械
|
|
US6899717B2
(en)
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20050283109A1
(en)
|
2003-03-07 |
2005-12-22 |
Peyman Gholam A |
Method and apparatus for lacrimal canal obstruction
|
|
US20050197614A1
(en)
|
2004-03-04 |
2005-09-08 |
Wilson Pritchard |
Occlusive biomedical devices, punctum plugs, and methods of use thereof
|
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
WO2005107708A1
(en)
*
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
US8685435B2
(en)
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
WO2006002365A2
(en)
|
2004-06-24 |
2006-01-05 |
Angiotech International Ag |
Microparticles with high loadings of a bioactive agent
|
|
ATE408432T1
(de)
|
2004-11-02 |
2008-10-15 |
Sydney Biotech Pty Ltd |
Extraokulare vorrichtung
|
|
MX2007005273A
(es)
|
2004-11-02 |
2007-07-19 |
Pfizer |
Formas polimorficas de 6-[2-(metilcarbamoil)fenilsulfanil]-3- e-[2-(piridin-2-il)etenil]indazol.
|
|
US8939910B2
(en)
|
2006-03-28 |
2015-01-27 |
Devicor Medical Products, Inc. |
Method for enhancing ultrasound visibility of hyperechoic materials
|
|
US11129690B2
(en)
|
2006-03-28 |
2021-09-28 |
Devicor Medical Products, Inc. |
Method for making hydrogel markers
|
|
SG170816A1
(en)
|
2006-03-31 |
2011-05-30 |
Qlt Plug Delivery Inc |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
|
US8197435B2
(en)
|
2006-05-02 |
2012-06-12 |
Emory University |
Methods and devices for drug delivery to ocular tissue using microneedle
|
|
US9173773B2
(en)
|
2006-06-21 |
2015-11-03 |
Johnson & Johnson Vision Care, Inc. |
Punctal plugs for the delivery of active agents
|
|
ES2565683T3
(es)
|
2006-09-15 |
2016-04-06 |
Xcovery, Inc. |
Compuestos inhibidores de quinasa
|
|
US20080114076A1
(en)
|
2006-11-09 |
2008-05-15 |
Alcon Manufacturing Ltd. |
Punctal plug comprising a water-insoluble polymeric matrix
|
|
US8080593B2
(en)
|
2006-11-29 |
2011-12-20 |
University Of Southern California |
Reversible thermoresponsive adhesives for implants
|
|
US8673286B2
(en)
|
2007-04-09 |
2014-03-18 |
Northwestern University |
DOPA-functionalized, branched, poly(aklylene oxide) adhesives
|
|
US20090227981A1
(en)
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
|
NZ580126A
(en)
|
2007-04-05 |
2012-03-30 |
Pfizer Prod Inc |
Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
|
|
US8231892B2
(en)
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
US9125807B2
(en)
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
|
US8821870B2
(en)
|
2008-07-18 |
2014-09-02 |
Allergan, Inc. |
Method for treating atrophic age related macular degeneration
|
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
|
US20100247606A1
(en)
|
2009-03-25 |
2010-09-30 |
Allergan, Inc. |
Intraocular sustained release drug delivery systems and methods for treating ocular conditions
|
|
CA2769162C
(en)
|
2009-07-31 |
2017-12-05 |
Ascendis Pharma As |
Biodegradable polyethylene glycol based water-insoluble hydrogels
|
|
JP5893566B2
(ja)
|
2009-10-29 |
2016-03-23 |
アセンディス ファーマ エー／エス |
生分解性ヒドロゲルの滅菌
|
|
US9320647B2
(en)
|
2010-03-31 |
2016-04-26 |
Ocuject, Llc |
Device and method for intraocular drug delivery
|
|
US8821457B2
(en)
|
2010-09-08 |
2014-09-02 |
Johnson & Johnson Vision Care, Inc. |
Punctal plug containing drug formulation
|
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
|
US20130202587A1
(en)
|
2011-08-25 |
2013-08-08 |
Randox Laboratories Ltd. |
Identification of genetic variants
|
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
|
CA2849192C
(en)
|
2011-10-12 |
2019-09-24 |
Ascendis Pharma Ophthalmology Division A/S |
Prevention and treatment of ocular conditions
|
|
JP6199883B2
(ja)
|
2011-12-05 |
2017-09-20 |
インセプト・リミテッド・ライアビリティ・カンパニーＩｎｃｅｐｔ，Ｌｌｃ |
医療用オルガノゲルプロセス及び組成物
|
|
WO2013126799A1
(en)
*
|
2012-02-22 |
2013-08-29 |
Trustees Of Tufts College |
Compositions and methods for ocular delivery of a therapeutic agent
|
|
WO2013165975A1
(en)
|
2012-04-30 |
2013-11-07 |
The Johns Hopkins University |
Electro-mechanically stretched micro fibers and methods of use thereof
|
|
US11779682B2
(en)
|
2012-04-30 |
2023-10-10 |
The Johns Hopkins University |
Electro-mechanically stretched micro fibers and methods of use thereof
|
|
WO2013177367A2
(en)
|
2012-05-23 |
2013-11-28 |
The Johns Hopkins University |
Compounds and methods of use thereof for treating neurodegenerative disorders
|
|
HK1204564A1
(en)
|
2012-06-25 |
2015-11-27 |
Bayer Healthcare Llc |
Topical ophthalmological pharmaceutical composition containing axitinib
|
|
MX373894B
(es)
|
2012-11-08 |
2020-07-09 |
Clearside Biomedical Inc |
Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
US10113033B2
(en)
|
2013-03-08 |
2018-10-30 |
Polyactiva Pty Ltd |
Polymer conjugate for delivery of a bioactive agent
|
|
NZ711392A
(en)
|
2013-03-08 |
2020-05-29 |
Polyactiva Pty Ltd |
Polymer conjugate for delivery of a bioactive agent
|
|
AU2014248460B2
(en)
|
2013-04-01 |
2019-04-11 |
Allergan, Inc. |
Microsphere drug delivery system for sustained intraocular release
|
|
US20160296627A1
(en)
|
2013-12-06 |
2016-10-13 |
Envisia Therapeutics Inc. |
Intracameral implant for treatment of an ocular condition
|
|
CA2936239A1
(en)
|
2014-01-16 |
2015-07-23 |
Ontogenesis, Llc |
Compositions and methods for the treatment of intraocular neovascularization and/or leakage
|
|
PL3102605T3
(pl)
|
2014-02-04 |
2019-06-28 |
Pfizer Inc. |
Połączenie antagonisty pd-1 i inhibitora vegfr do leczenia nowotworu
|
|
KR20150115533A
(ko)
*
|
2014-04-04 |
2015-10-14 |
씨제이제일제당 (주) |
1,5-디아미노펜탄의 정제방법
|
|
AU2015360469B2
(en)
|
2014-12-10 |
2021-03-25 |
Incept, Llc |
Hydrogel drug delivery implants
|
|
WO2016178150A1
(en)
|
2015-05-05 |
2016-11-10 |
Shilpa Medicare Limited |
Novel polymorphs of axitinib
|
|
EP4279064A3
(en)
|
2015-05-12 |
2024-02-28 |
Incept, LLC |
Drug delivery from hydrogels
|
|
KR20260025887A
(ko)
|
2015-06-06 |
2026-02-24 |
클라우드브레이크 테라퓨틱스, 엘엘씨 |
익상편을 치료하기 위한 조성물 및 방법
|
|
MY193229A
(en)
|
2015-06-16 |
2022-09-26 |
Merck Patent GmbH |
Pd-l1 antagonist combination treatments
|
|
EP3324902B1
(en)
|
2015-07-22 |
2024-12-18 |
Incept, LLC |
Coated punctal plug
|
|
WO2017015616A1
(en)
*
|
2015-07-22 |
2017-01-26 |
Envisia Therapeutics, Inc. |
Ocular protein delivery
|
|
AU2016361579B2
(en)
|
2015-11-25 |
2022-08-04 |
Incept, Llc |
Shape changing drug delivery devices and methods
|
|
AU2017274195B2
(en)
|
2016-06-02 |
2022-04-07 |
Ads Therapeutics Llc |
Compositions and methods of using nintedanib for improving glaucoma surgery success
|
|
EP3515406B1
(en)
*
|
2016-09-23 |
2024-07-24 |
Incept, LLC |
Intracameral drug delivery depots
|
|
WO2018059556A1
(zh)
|
2016-09-29 |
2018-04-05 |
贝达药业股份有限公司 |
激酶抑制剂化合物的多晶型、含其的药物组合物及其制备方法和应用
|
|
JP7407595B2
(ja)
|
2016-10-05 |
2024-01-04 |
タイタン ファーマシューティカルズ インコーポレイテッド |
バースト放出を低減する薬剤送達用の埋込可能な装置
|
|
US20190388522A1
(en)
|
2017-01-25 |
2019-12-26 |
Iconic Therapeutics, Inc. |
Methods for treating disorders associated with angiogenesis and neovascularization
|
|
EP3600437A4
(en)
|
2017-03-31 |
2021-01-06 |
Rowan University |
OPTICALLY CLEAR IN-SITU EDUCATION OF BIODEGRADABLE NANOCARRIERS FOR EYE THERAPY AND THE SAME USING METHOD
|
|
EP4537830A3
(en)
|
2017-06-13 |
2025-06-11 |
EyePoint Pharmaceuticals, Inc. |
Bioerodible drug delivery devices
|
|
US20190192341A1
(en)
|
2017-11-09 |
2019-06-27 |
Allergan, Inc. |
Sustained-Release Implants for Lowering Intraocular Pressure with Extended Duration of Effect
|
|
KR20200131839A
(ko)
|
2018-03-16 |
2020-11-24 |
노파르티스 아게 |
안질환의 치료 방법
|
|
CA3125488A1
(en)
|
2019-01-04 |
2020-07-09 |
Ascendis Pharma Oncology Division A/S |
Induction of sustained local inflammation
|
|
AU2020204785A1
(en)
|
2019-01-04 |
2021-06-03 |
Ascendis Pharma Oncology Division A/S |
Sustained local drug levels for innate immune agonists
|
|
PH12021551591A1
(en)
|
2019-01-04 |
2022-04-18 |
Ascendis Pharma Oncology Div A/S |
Conjugates of pattern recognition receptor agonists
|
|
EP3906065B1
(en)
|
2019-01-04 |
2025-04-30 |
Ascendis Pharma Oncology Division A/S |
Prr agonist for use in the treatment of cancer
|
|
KR20210135560A
(ko)
|
2019-03-05 |
2021-11-15 |
에어리 파마슈티컬즈, 인코포레이티드 |
안구 질환 또는 장애를 치료하는 약학 조성물
|
|
CN113939271B
(zh)
*
|
2019-04-25 |
2025-04-04 |
视尔普斯眼科公司 |
眼用水凝胶酪氨酸激酶抑制剂植入物
|
|
WO2020243608A1
(en)
|
2019-05-31 |
2020-12-03 |
Dose Medical Corporation |
Bioerodible polyester polymer implants and related methods of use
|
|
PT3884929T
(pt)
*
|
2020-03-25 |
2023-08-09 |
Ocular Therapeutix Inc |
Implante ocular contendo um inibidor da tirosina cinase
|
|
WO2021262645A1
(en)
|
2020-06-22 |
2021-12-30 |
Ohio State Innovation Foundation |
Redox-responsive nanoparticle compositions for ocular delivery of therapeutics
|
|
US20220080044A1
(en)
|
2020-09-14 |
2022-03-17 |
National Yang-Ming University |
Method for preventing or treating peripheral arterial occlusive disease
|
|
IL301640A
(en)
*
|
2020-10-27 |
2023-05-01 |
Ocular Therapeutix Inc |
Ocular implant containing an active agent
|
|
US12251466B2
(en)
|
2022-04-20 |
2025-03-18 |
Pramand LLC |
Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
|